Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Mol Allergy. 2007 Jul 4;5:3.Click here to read Click here to read Links

Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics.

Behrmann J.

Programmes de bioéthique, Université de Montréal, C.P. 6128, succursale centre-ville, Montréal, Québec, H3C 3J7, Canada. jason.behrmann@mail.mcgill.ca

While biotechnology-derived allergen therapeutics show promise in improving the safety of immunotherapy, they may prove to have additional benefits in comparison to conventional allergenic extracts that deserve commentary. These issues range from product stability and compatibility to medical practice issues, which will be the focus of this article.

PMID: 17608954 [PubMed]

PMCID: PMC1929119